| Application no. and date | 12782170.0 (espacenet) (Federated) (European Patent Register), 20120511 | | Patent/reg. no. and date | DK/EP 2707384, 20220406 | | Publication date | 20140319 | | Priority no. and date | US 201161484836 P, 20110511 | | EP pub. no. and date |
EP 2707384 20140319 | | Effective date | | | Applicant/owner | Apellis Pharmaceuticals, Inc., 100 5th Avenue
Waltham, MA 02451, US | | Applicant ref. no. | V443358DK00 | | Inventor | FRANCOIS, Cedric, 1434 Goddard Avenue
Louisville, KY 40204, US,
DESCHATELETS, Pascal, 9506 Delphinium Street
Prospect, KY 40059, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 38/04 (2006.01) , A61P 37/00 (2006.01) , C07K 7/00 (2006.01) , C12N 5/00 (2006.01) | | Title | Cellereaktiv, langtidsvirkende eller målrettede compstatinanaloger og anvendelser deraf | | Int. application no. | US2012037648 | | Int. publication no. | WO2012155107 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
